Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T08:06:03.623Z Has data issue: false hasContentIssue false

3D printing for regenerative medicine: From bench to bedside

Published online by Cambridge University Press:  12 February 2015

Juan Li
Affiliation:
Columbia University, USA, and Sichuan University, China
Ling He
Affiliation:
Columbia University, USA; lh2685@columbia.edu
Chen Zhou
Affiliation:
Columbia University, USA; cz2329@columbia.edu
Yue Zhou
Affiliation:
Columbia University, USA; yz2643@columbia.edu
Yanying Bai
Affiliation:
Columbia University, USA
Francis Y. Lee
Affiliation:
Columbia University, USA; fl127@columbia.edu
Jeremy J. Mao
Affiliation:
Columbia University, USA; jmao@columbia.edu

Abstract

Organ shortage is a severe challenge worldwide. Three-dimensional (3D) printing, a rapidly developing engineering and materials science tool, holds considerable promise in generating implantable organ scaffolds that may reduce or eliminate organ shortage. However, translation of 3D printing into clinical therapies has been astonishingly slow and certainly has not matched the pace of technology development. This review outlines challenges and opportunities for the application of 3D printing in tissue and organ regeneration, with emphasis on in vivo applications of 3D-printed scaffolds. Three-dimensional-printed scaffolds for the regeneration of complex tissues and organs, including bone, cartilage, tooth, and skin, serve as prototypes for 3D printing of other tissues and organs such as the liver, kidney, or heart. The aspiration to reduce or eliminate organ shortage appears to hinge on the translation of 3D bioprinting technologies into preclinical studies and clinical trials. The remaining challenges of cell survival, directed differentiation, angiogenesis, and metabolic exchange are far from trial and need to be addressed. Three-dimensional-printed materials will remain a biomaterials and engineering showcase unless applications in preclinical and clinical models are realized. In balance, 3D printing holds considerable promise in regenerative medicine as a unique approach to address organ shortage.

Information

Type
Research Article
Copyright
Copyright © Materials Research Society 2015 
Figure 0

Figure 1. Schematics of three-dimensional (3D) bioprinting for tissue and organ regeneration. (a) Fabrication of 3D anatomical-shaped scaffolds with or without cell printing and/or deposition of molecular signaling cues. (b) In vitro culture of bioprinted scaffolds with cells. (c) In vivo implantation of 3D-bioprinted scaffolds. (d) Integration with native tissue and regeneration. Tissues represented are the lungs, liver, heart, kidney, blood vessels, tooth, skin, bone, joint, and ear. ★Images reprinted with permission from Reference 77. © 2014 Genetic Engineering and Biotechnology News. ◆Images reprinted with permission from Reference 78. © 2014 Columbia University Medical Center. ▲Image reprinted with permission from Reference 79. © 2014 Beckman Institute, University of Illinois at Urbana-Champaign.

Figure 1

Table I. Three-dimensional printing for bone regeneration: in vivo studies.

Figure 2

Table II. Three-dimensional printing for cartilage regeneration: in vivo studies.

Figure 3

Table III. Three-dimensional printing for tooth regeneration: in vivo studies.

Figure 4

Table IV. Three-dimensional printing for skin regeneration: in vivo studies.

Figure 5

Table V. Three-dimensional printing for regeneration of other tissues: in vivo studies.